Diet and gut microbiome synergy explains better immunotherapy response in obesity

A new study reveals that the combined effects of diet and gut microbiome composition underlie why obesity is associated with improved efficacy of cancer immunotherapy. The findings suggest that specific dietary and microbial factors may enhance immune checkpoint inhibitor treatments. This research could lead to personalized dietary interventions to boost immunotherapy outcomes in cancer patients.

Sources (1)